Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cumberland Pharmaceuticals Inc

Current price
1.57 USD -0.01 USD (-0.63%)
Last closed 1.56 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 23 107 694 USD
Yield for 12 month -16.49 %
21.11.2021 - 28.11.2021

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Address: 1600 West End Avenue, Nashville, TN, United States, 37203

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

8.5 USD

P/E ratio

Dividend Yield

Current Year

+39 552 507 USD

Last Year

+42 010 949 USD

Current Quarter

+9 353 066 USD

Last Quarter

+10 085 926 USD

Current Year

+28 549 942 USD

Last Year

+32 892 428 USD

Current Quarter

+6 627 770 USD

Last Quarter

+8 320 336 USD

Key Figures CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 274 865 USD
Operating Margin TTM -30.32 %
PE Ratio
Return On Assets TTM -4.44 %
PEG Ratio
Return On Equity TTM -19.41 %
Wall Street Target Price 8.5 USD
Revenue TTM 39 552 508 USD
Book Value 2.1 USD
Revenue Per Share TTM 2.77 USD
Dividend Share
Quarterly Revenue Growth YOY 2.5 %
Dividend Yield
Gross Profit TTM 32 892 428 USD
Earnings Share -0.44 USD
Diluted Eps TTM -0.44 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -15.88 %

Dividend Analytics CPIX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 06.07.2007
Dividend Date

Stock Valuation CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.5869
Price Sales TTM 0.5842
Enterprise Value EBITDA 9.34
Price Book MRQ 0.7806

Financials CPIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CPIX

For 52 weeks

1.43 USD 2.36 USD
50 Day MA 1.93 USD
Shares Short Prior Month 20 436
200 Day MA 1.82 USD
Short Ratio 1.51
Shares Short 16 968
Short Percent 0.21 %

Dynamics of changes in the value of assets




411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds



208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics



2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics